New challenges in HIV prevention and care are emerging due to climate change, according to a review published earlier this month in Current Opinions in Infectious Disease.
atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics | Psychedelic Invest
Strategic investment in Beckley Psytech reinforces atai’s position as the biopharmaceutical company with the largest and most diverse portfolio of clinical-stage psychedelic candidates Two patent-protected,